Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | CPA1 | P15085 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 5/20 | 0.34 |
| ▸ | PPARG | P37231 | 9/20 | 0.33 |
| ▸ | PPARA | Q07869 | 9/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6533599 | 0.93 | PPARG (0.39) | MMEACECPA1ACE2HTR2A | |
| SCHEMBL6532383 | 0.91 | PPARG (0.40) | PPARGPPARAROCK2ROCK1MMP1 | |
| SCHEMBL6534035 | 0.89 | ACACB (0.38) | PPARGPPARAMAOBROCK2ROCK1 | |
| SCHEMBL6532684 | 0.85 | PPARG (0.38) | PPARGPPARAROCK2ROCK1 | |
| SCHEMBL6533257 | 0.85 | ROCK2 (0.34) | PPARGPPARAMAOBROCK2 | |
| SCHEMBL6532334 | 0.84 | PPARG (0.35) | PPARGPPARA | |
| SCHEMBL6532874 | 0.84 | PPARG (0.40) | PPARGPPARAROCK2ROCK1MMP1 | |
| SCHEMBL6532609 | 0.84 | PPARG (0.47) | PPARGPPARAMMP1MMP2MMP9 | |
| SCHEMBL6532514 | 0.83 | CXCR1 (0.34) | PPARGPPARA | |
| SCHEMBL6533886 | 0.82 | PPARG (0.36) | PPARGPPARAROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040127-A1 | NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2005-05-06 | — | — | WO | claimed |
| WO-2005040127-A1 | NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2005-05-06 | — | — | WO | disclosed |